// App-Quantinova.ai

227 : Predictors of presenteeism and absenteeism in patients commencing treatment with methotrexate monotherapy or biologic therapy for rheumatoid arthritis

Researchers

Presenter

  • Sarah Leggett

Principal Investigators

  • Mark Lunt

  • Anne Barton

  • Kimme Hyrich

  • Karen Walker-Bone

  • Suzanne Verstappen

Medical Centers

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

  • Arthritis Research UK/MRC Centre for Musculoskeletal Health and Work, The University of Southampton, Southampton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Rheumatoid arthritis

  • Depression

  • Inflammatory Arthritis

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A